Josefine Waldthaler
- Department of Clinical Neuroscience
- Division of Neuro
About me
I am a Team Leader for Functional Neuroimaging in Movement Disoders in Daniel Lundqvist's reasearch group at the Neuro Division of CNS interested in the cognitive and behavioral aspects of Parkinson's disease and other neurodegenerative disorders. I did my doctoral training at the University of Regensburg and postdoctoral training as a SUCCESS fellow at Philipps-University Marburg. As a board-certified neurologist, I work 50% of my time as a movement disorders specialist at Academic Specialist Centre Stockholm.
I am also afliated with Philipps University Marburg and the Department of Neurology at University Hospital Marburg where I hold an appointment as docent ("Privatdozent") and am involved in teaching and collaborate on research projects.
Our current research focuses on changes in brain activity in Parkinson's disease and their modulation by dopamine replacement therapy and deep brain stimulation (DBS) with the goal of improving our understanding of the complex interplay between motor, cognitive, and behavioral symptoms of Parkinson's disease. The primary tools we are using to pursue these goals are magneto- / electroencephalography (M/EEG) in combination with eye-tracking and in-depth clinical characterisations including neuropsychological assessments.
As a postdoc at the Swedish National Facility for Magnetoencephalography (NatMEG), I consider myself the bridge from NatMEG into the clinics. I assist researchers with initiating, planning and running projects in clinical populations.
Selected publications
- Article: NPJ PARKINSONS DISEASE. 2024;10(1):51Vinding MC; Waldthaler J; Eriksson A; Manting CL; Ferreira D; Ingvar M; Svenningsson P; Lundqvist D
- Article: BRAIN COMMUNICATIONS. 2023;5(2):fcad121Waldthaler J; Sperlich A; Stuessel C; Steidel K; Timmermann L; Pedrosa DJ
- Article: NEUROIMAGE-CLINICAL. 2023;37:103314Waldthaler J; Sperlich A; Koenig A; Stuessel C; Bremmer F; Timmermann L; Pedrosa D
- Article: BEHAVIOURAL BRAIN RESEARCH. 2022;422:113763Waldthaler J; Vinding MC; Eriksson A; Svenningsson P; Lundqvist D
- Article: BRAIN STIMULATION. 2021;14(5):1109-1117Waldthaler J; Bopp M; Kuehn N; Bacara B; Keuler M; Gjorgjevski M; Carl B; Timmermann L; Nimsky C; Pedrosa DJ
Articles
- Article: MOVEMENT DISORDERS. 2025;40(8):1551-1560Wiesman AI; Vinding MC; Tsitsi P; Svenningsson P; Waldthaler J; Lundqvist D
- Article: JOURNAL OF NEUROENGINEERING AND REHABILITATION. 2025;22(1):29Engel D; Greulich RS; Parola A; Vinehout K; Student J; Waldthaler J; Timmermann L; Bremmer F
- Article: ENDOSCOPY. 2025;57(01):31-40Waldthaler A; Warnqvist A; Waldthaler J; Vujasinovic M; Ghorbani P; von Seth E; Arnelo U; Lohr M; Bergquist A
- Article: JOURNAL OF NEUROSURGICAL SCIENCES. 2024;68(1):59-69Carl B; Bopp M; Sass B; Waldthaler J; Timmermann L; Nimsky C
- Article: SCIENTIFIC DATA. 2024;11(1):150Vinding MC; Eriksson A; Comarovschii I; Waldthaler J; Manting CL; Oostenveld R; Ingvar M; Svenningsson P; Lundqvist D
- Article: FRONTIERS IN INTEGRATIVE NEUROSCIENCE. 2023;17:1249554Tsitsi P; Nilsson M; Waldthaler J; Seimyr GO; Larsson O; Svenningsson P; Markaki I
- Article: JOURNAL OF NEUROPSYCHOLOGY. 2023;17(2):251-263Waldthaler J; Stock L; Krueger-Zechlin C; Deeb Z; Timmermann L
- Journal article: CLINICAL NEUROPHYSIOLOGY. 2023;148:e40Waldthaler J; Spehrlich A; Stüssel C; Steidel K; Timmermann L; Pedrosa D
- Article: FRONTIERS IN HUMAN NEUROSCIENCE. 2022;16:762380Student J; Engel D; Timmermann L; Bremmer F; Waldthaler J
- Article: JIMD REPORTS. 2022;63(1):93-100Tsitsi P; Markaki I; Waldthaler J; Machaczka M; Svenningsson P
- Article: NEUROPSYCHOLOGIA. 2021;163:108082Waldthaler J; Stock L; Krueger-Zechlin C; Timmermann L
- Article: JOURNAL OF NEUROPHYSIOLOGY. 2021;126(4):1076-1089Engel D; Student J; Schwenk JCB; Morris AP; Waldthaler J; Timmermann L; Bremmer F
- Journal article: DGNEUROLOGIE. 2021;4(Suppl 1):99-102Waldthaler J; Timmermann L
- Article: FRONTIERS IN AGING NEUROSCIENCE. 2020;12:120Stock L; Krueger-Zechlin C; Deeb Z; Timmermann L; Waldthaler J
- Article: BRAIN COMMUNICATIONS. 2020;2(1):fcaa052Vinding MC; Tsitsi P; Waldthaler J; Oostenveld R; Ingvar M; Svenningsson P; Lundqvist D
- Article: NPJ PARKINSONS DISEASE. 2019;5:11Waldthaler J; Tsitsi P; Svenningsson P
- Article: ANNALS OF NEUROLOGY. 2019;85(6):852-864Strotzer QD; Anthofer JM; Faltermeier R; Brawanski AT; Torka E; Waldthaler JA; Kohl Z; Fellner C; Beer AL; Schlaier JR
- Journal article: NEUROLOGY. 2019;92(15_supplement)Waldthaler J; Stock L; Krüger-Zechlin C; Timmermann L
- Article: SCIENTIFIC REPORTS. 2019;9(1):2604Vinding MC; Tsitsi P; Piitulainen H; Waldthaler J; Jousmaki V; Ingvar M; Svenningsson P; Lundqvist D
- Journal article: NEUROLOGIE UP2DATE. 2019;2(01):31-46Waldthaler J; Timmermann L
- Article: CLINICAL PARKINSONISM & RELATED DISORDERS. 2019;1:102-108Waldthaler J; Krueger-Zechlin C; Stock L; Deeb Z; Timmermann L
- Article: NEUROLOGY-GENETICS. 2018;4(4):e259Paucar M; Waldthaler J; Svenningsson P
- Article: JOURNAL OF THE NEUROLOGICAL SCIENCES. 2017;381:141-143Blume J; Rothenfusser E; Schlaier J; Bogdahn U; Lange M
- Article: ACTA NEUROCHIRURGICA. 2017;159(9):1721-1726Blume J; Schlaier J; Rothenfusser E; Anthofer J; Zeman F; Brawanski A; Bogdahn U; Lange M
- Article: CLINICAL NEUROLOGY AND NEUROSURGERY. 2017;159:87-92Blume J; Lange M; Rothenfusser E; Doenitz C; Bogdahn U; Brawanski A; Schlaier J
- Article: FRONTIERS IN NEUROLOGY. 2017;8:295Blume J; Beniaminov S; Bjorkvall CK; Machaczka M; Svenningsson P
- Article: JOURNAL OF MOVEMENT DISORDERS. 2017;10(1):59-61Blume J; Weissert R
- Article: ENEUROLOGICALSCI. 2015;1(3-4):51-53Blume J; Köstler J; Weissert R
- Show more
All other publications
- Preprint: MEDRXIV. 2025Waldthaler J; Comarovschii I; Lundqvist D
- Preprint: MEDRXIV. 2025Bingöl D; Klimaschewski C; Timmermann L; Pedrosa D; Waldthaler J
- Preprint: MEDRXIV. 2025Helson P; Benyahiya E; Manikandan S; Waldthaler J; Vinding M; Lundqvist D; Svenningsson P; Mitra D; Kumar A
- Conference publication: CLINICAL NEUROPHYSIOLOGY PRACTICE. 2025;10:S719-S720af Edholm K; Vinding MC; Pfeiffer C; Svenningsson A; Fransen E; Sundgren M; Sjostrom H; Edvall N; Lundqvist D; Waldthaler J
- Preprint: MEDRXIV. 2024;MEDRXIVWiesman AI; Vinding MC; Tsitsi P; Svenningsson P; Waldthaler J; Lundqvist D
- Preprint: ARXIV. 2023Uribarri G; von Huth SE; Waldthaler J; Svenningsson P; Fransén E
- Review: EUROPEAN JOURNAL OF NEUROLOGY. 2023;30(8):2544-2556Pedrosa AJ; Waldthaler J; Muegge F; Timmermann L; Pedrosa DJ
- Preprint: MEDRXIV. 2023Engel D; Greulich S; Parola A; Vinehout K; Dowiasch S; Waldthaler J; Timmermann L; Rothkopf C; Bremmer F
- Conference publication: MOVEMENT DISORDERS. 2022;37:S555Waldthaler J; Sperling A; Koenig A; Bremmer F; Timmermann L; Pedrosa D
- Preprint: RESEARCH SQUARE. 2022Vinding M; Eriksson A; Manting C; Waldthaler J; Ferreira D; Ingvar M; Svenningsson P; Lundqvist D
- Preprint: BIORXIV. 2022Waldthaler J; Sperlich A; König A; Stüssel C; Bremmer F; Timmermann L; Pedrosa D
- Review: NEUROPSYCHOLOGY REVIEW. 2021;31(4):628-642Waldthaler J; Stock L; Student J; Sommerkorn J; Dowiasch S; Timmermann L
- Preprint: BIORXIV. 2021Engel D; Student J; Schwenk JCB; Morris A; Waldthaler J; Timmermann L; Bremmer F
- Preprint: MEDRXIV. 2021Vinding M; Eriksson A; Ting Low CM; Waldthaler J; Ferreira D; Ingvar M; Svenningsson P; Lundqvist D
- Letter: MOVEMENT DISORDERS. 2021;36(1):266-268Waldthaler J; Stock L; Sommerkorn J; Krueger-Zechlin C; Timmermann L
- Conference publication: MOVEMENT DISORDERS. 2019;34:S853-S854Ghilardi MG; Stock L; Kruger-Zechlin C; Deeb Z; Fonoff E; Timmermann L; Waldthaler J
- Conference publication: MOVEMENT DISORDERS. 2019;34:S196Steidel K; Waldthaler J; Eggers C; Pedrosa D
- Conference publication: MOVEMENT DISORDERS. 2019;34:S715Waldthaler J; Stock L; Krueger-Zechlin C; Timmermann L
- Preprint: BIORXIV. 2019Vinding M; Tsitsi P; Waldthaler J; Oostenveld R; Ingvar M; Svenningsson P; Lundqvist D
- Other: FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE. 2019;87(8):445-461Waldthaler J; Timmermann L
- Conference publication: JOURNAL OF NEURAL TRANSMISSION. 2019;126(5):664Stock L; Kruger-Zechlin C; Deeb Z; Timmermann L; Waldthaler J
- Conference publication: NEUROLOGY. 2019;92(15)Waldthaler J; Stock L; Kruger-Zechlin C; Timmermann L
- Conference publication: MOVEMENT DISORDERS. 2018;33:S565Waldthaler J; Tsitsi P; Seimyr GO; Benfatto MN; Svenningsson P
- Letter: MOVEMENT DISORDERS. 2018;33(10):1661-1662Waldthaler J; Tsitsi P; Seimyr GO; Benfatto MN; Svenningsson P
- Preprint: BIORXIV. 2018Vinding M; Tsitsi P; Piitulainen H; Waldthaler J; Jousmäki V; Ingvar M; Svenningsson P; Lundqvist D
- Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2015;22:432Baldaranov D; Khomenko A; Blume J; Kassubek J; Mueller H-P; Johannesen S; Kobor I; Grassinger J; Bruun T; Schuierer G; Schulte-Mattler W; Schneider A; Deppe M; Bogdahn U
- Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2015;22:142Johannesen S; Baldaranov D; Khomenko A; Blume J; Kassubek J; Mueller H-P; Kobor I; Bruun T; Grassinger J; Schuierer G; Schulte-Mattler W; Schneider A; Deppe M; Bogdahn U
- Show more
Grants
- Swedish Research Council1 December 2024 - 30 November 2027There is increasing evidence suggesting that the clinical presentation of Parkinson´s disease (PD) is influenced by complex interactions between neurodegeneration and potentially counteracting mechanisms. However, these compensatory mechanisms have not received much attention in terms of their potential therapeutic value. studies examining the interaction between nigrostriatal degeneration and cerebral compensation and its failure as a potential driver of early-stage PD symptoms and progression are lacking.Our multinational consortium, comprised of experts in molecular and structural brain imaging and neurophysiology with extensive research experience in movement disorders, aims to address this gap. Together, we have developed five work packages that primarily focus on analysing multimodal imaging data in existing cohorts of early PD patients. Our goal is to identify neurobiological patterns that characterise early PD and how nigrostriatal neurodegeneration and cerebral counteracting mechanismscontribute to specific features of early disease, such as motor or cognitive symptom burden. By validating these emerging concepts with cross-national data and protocol sharing, our aim is to establish a foundation for staging models that integrate both neurodegenerative and compensatory aspects of the brain. Additionally, these findings may enhance the translational potential of possible therapies that target both processes.